These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12187179)

  • 1. Quantifying the physician contribution to managed care pharmacy expenses: a random effects approach.
    Cowen ME; Strawderman RL
    Med Care; 2002 Aug; 40(8):650-61. PubMed ID: 12187179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive modeling of total healthcare costs using pharmacy claims data: a comparison of alternative econometric cost modeling techniques.
    Powers CA; Meyer CM; Roebuck MC; Vaziri B
    Med Care; 2005 Nov; 43(11):1065-72. PubMed ID: 16224298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of antidepressant prescribing concentration to treatment duration and cost.
    Hodgkin D; Merrick EL; Hiatt D
    J Ment Health Policy Econ; 2012 Mar; 15(1):3-11. PubMed ID: 22611088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization.
    Brufsky JW; Ross-Degnan D; Calabrese D; Gao X; Soumerai SB
    Med Care; 1998 Mar; 36(3):321-32. PubMed ID: 9520957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical care expenditures under gatekeeper and point-of-service arrangements.
    Escarce JJ; Kapur K; Joyce GF; Van Vorst KA
    Health Serv Res; 2001 Dec; 36(6 Pt 1):1037-57. PubMed ID: 11775666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?
    Crown WH; Berndt ER; Baser O; Finkelstein SN; Witt WP; Maguire J; Haver KE
    Front Health Policy Res; 2004; 7():95-127. PubMed ID: 15612337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing prescribing patterns and increasing prescription expenditures in Medicaid.
    Fink KS; Byrns PJ
    Ann Fam Med; 2004; 2(5):488-93. PubMed ID: 15506586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE; Gurwitz JH; Fish LS
    Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.
    Fishman PA; Goodman MJ; Hornbrook MC; Meenan RT; Bachman DJ; O'Keeffe Rosetti MC
    Med Care; 2003 Jan; 41(1):84-99. PubMed ID: 12544546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling physician practice patterns using diagnostic episode clusters.
    Cave DG
    Med Care; 1995 May; 33(5):463-86. PubMed ID: 7739272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction.
    Hadley J; Mitchell JM; Sulmasy DP; Bloche MG
    Health Serv Res; 1999 Apr; 34(1 Pt 2):307-21. PubMed ID: 10199677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing the cost and value of medications: the dilemma facing clinicians.
    Avorn J
    Pharmacoeconomics; 2002; 20 Suppl 3():67-72. PubMed ID: 12457426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of standardized patients to assess between-physician variations in resource utilization.
    McLeod PJ; Tamblyn RM; Gayton D; Grad R; Snell L; Berkson L; Abrahamowicz M
    JAMA; 1997 Oct; 278(14):1164-8. PubMed ID: 9326476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Optimization And The Continuity Of Physicians In Medicaid Managed Care.
    Ndumele CD; Staiger B; Ross JS; Schlesinger MJ
    Health Aff (Millwood); 2018 Jun; 37(6):929-935. PubMed ID: 29863934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do doctors behave when some (but not all) of their patients are in managed care?
    Glied S; Zivin JG
    J Health Econ; 2002 Mar; 21(2):337-53. PubMed ID: 11939245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
    Benedetto SR; Sloan AS; Duncan BS
    Am J Health Syst Pharm; 2000 Oct; 57(19):1778-85. PubMed ID: 11030030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physician survey of the effect of drug sample availability on physicians' behavior.
    Chew LD; O'Young TS; Hazlet TK; Bradley KA; Maynard C; Lessler DS
    J Gen Intern Med; 2000 Jul; 15(7):478-83. PubMed ID: 10940134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.